caffeic acid has been researched along with Hypertension in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ | 1 |
| Asgaonkar, K; Daga, Y; Gupta, M; Mahadik, I; Patil, S; Randive, V; Sagar, A; Shevate, K | 1 |
| Barre, DE; Mizier-Barre, KA | 1 |
| Adedapo, AA; Ademosun, AO; Ajibade, TO; Oboh, G; Ojueromi, OO; Omayone, TP; Oyagbemi, AA | 1 |
| Agunloye, OM; Bello, GT; Oboh, G; Oyagbemi, AA | 1 |
| Belščak-Cvitanović, A; Bugarski, D; Grujić-Milanović, J; Ivanov, M; Jovović, Dj; Mihailovic-Stanojevic, N; Miloradović, Z | 1 |
| Ikami, T; Ikeda, K; Kayano, Y; Kobayakawa, A; Li, PG; Mitani, T; Xu, JW; Yamori, Y | 1 |
1 review(s) available for caffeic acid and Hypertension
| Article | Year |
|---|---|
The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus.
Topics: Acrolein; Animals; Caffeic Acids; Chlorogenic Acid; Cinnamates; Coumaric Acids; Diabetes Mellitus, Type 2; Dyslipidemias; Humans; Hyperglycemia; Hypertension; Inflammation; Obesity, Abdominal; Polypharmacy | 2020 |
6 other study(ies) available for caffeic acid and Hypertension
| Article | Year |
|---|---|
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
Topics: Amides; Amines; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Caffeic Acids; Cells, Cultured; Esters; Hypertension; Losartan; Male; Molecular Structure; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstrictor Agents | 2012 |
Topics: Antihypertensive Agents; Diabetes Mellitus; Humans; Hypertension; Indoles; Molecular Docking Simulation | 2023 |
Effects of caffeine and caffeic acid on selected biochemical parameters in L-NAME-induced hypertensive rats.
Topics: Animals; Caffeic Acids; Caffeine; Hypertension; NG-Nitroarginine Methyl Ester; Rats | 2021 |
Caffeic and chlorogenic acids modulate altered activity of key enzymes linked to hypertension in cyclosporine-induced hypertensive rats.
Topics: 5'-Nucleotidase; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Caffeic Acids; Captopril; Chlorogenic Acid; Cyclosporine; Hypertension; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Rats; Rats, Wistar | 2020 |
Antioxidant and antihypertensive activity of extract from Thymus serpyllum L. in experimental hypertension.
Topics: Animals; Antihypertensive Agents; Antioxidants; Caffeic Acids; Chromatography, High Pressure Liquid; Cinnamates; Depsides; Diet, Mediterranean; Ferric Compounds; Flavonoids; Free Radical Scavengers; Gallic Acid; Hypertension; Male; Nitric Oxide; Phenols; Phytotherapy; Plant Extracts; Rats; Rats, Inbred SHR; Rats, Wistar; Rosmarinic Acid; Sorbitol; Thymus Plant | 2013 |
Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin II; Animals; Antioxidants; Caffeic Acids; Cell Division; DNA-Binding Proteins; Drug Interactions; Enzyme Inhibitors; HSP90 Heat-Shock Proteins; Hypertension; Janus Kinase 2; Male; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Muscle, Smooth, Vascular; Phosphorylation; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; STAT1 Transcription Factor; Stroke; Superoxides; Trans-Activators; Tyrosine; Tyrphostins; Vasoconstrictor Agents | 2005 |